Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026)
Envista Holdings (NVST) recorded quarterly Asset Writedowns and Impairment of $4.4 million in Q2 2026, down 53.68% quarter-over-quarter from $9.5 million in Q4 2025, and up 238.46% on a YoY basis from $1.3 million in Q2 2025.
Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
Envista Holdings' Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at $4.4 million for Q2 2026.
- In Q2 2026, Asset Writedowns and Impairment rose 238.46% year-over-year to $4.4 million; the TTM figure through Apr 2026 stood at $13.9 million (down 98.8% YoY), while the FY2025 annual figure was $9.5 million, down 44.44% from the prior year.
- Asset Writedowns and Impairment was $4.4 million for Q2 2026 at Envista Holdings, down from $9.5 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.2 billion in Q2 2024 to a low of -$700000.0 in Q4 2022.
- Historically, Asset Writedowns and Impairment has averaged $107.3 million across 5 years, with a median of $2.0 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Asset Writedowns and Impairment slumped 81.32% in 2022, then surged 238.46% in 2026.
- A 5-year view of Asset Writedowns and Impairment shows it stood at -$700000.0 in 2022, then jumped by 128.57% to $200000.0 in 2023, then soared by 576800.0% to $1.2 billion in 2024, then sank by 99.18% to $9.5 million in 2025, then tumbled by 53.68% to $4.4 million in 2026.
- The last three Asset Writedowns and Impairment figures came in at $4.4 million (Q2 2026), $9.5 million (Q4 2025), and $1.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 4.40 Mn |
| Apr 3, 2026 | 4.40 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Mar 28, 2025 | 1.30 Mn |
| Mar 28, 2025 | 1.30 Mn |
| Jun 28, 2024 | 1.15 Bn |
| Jun 28, 2024 | 1.15 Bn |
| Mar 29, 2024 | 4.50 Mn |
| Mar 29, 2024 | 4.50 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | -700,000.00 |
| Dec 31, 2022 | -700,000.00 |
| Sep 30, 2022 | 1.70 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Jul 1, 2022 | -100,000.00 |
| Jul 1, 2022 | -100,000.00 |